| Suggest |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > Barbados as an Offshore Jurisdiction |
|
Suggest - Barbados as an Offshore Jurisdiction
This jurisdiction has a number of taxes that need to be overcome tha According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product t right off the top make this a less than favorable jurisdiction. Wh ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in y go offshore if taxation in the offshore jurisdiction is going to b lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e a problem. Barbados has a number of Tax Treaties that turn us awa here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe y from this jurisdiction right off the top. Tax treaties open the do d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro r to wholesale fishing expeditions where records are turned over jus ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc t to see if maybe there was a tax violation. As of the year 2006, B easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi arbados has 14 tax treaties in effect with the following countries: nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically The Caribbean Common Market (CARICOM), the United States, Canada, Un and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ited Kingdom, Finland, Norway, Malta, Sweden, Switzerland, Cuba, Ven ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi zuela, China, Mauritius and Botswana. Treaties with Austria and the ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a Netherlands are expected to be added in soon. The Barbados / US tax dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod treaty dates from 1984, and was accompanied by an exchange of tax in cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin formation agreement The US treaty was further amended in 2004 in wha tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen t was said to be an attempt to counter tax evasion. Here is a link t t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel the Barbados/USA Tax Treaty: http://www.irs.gov/pub/irs-trty/barba ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust dos.pdf Barbados has too many Tax Treaties for us to take this juri y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products sdiction seriously as being able to preserve privacy. Barbados has . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de no anonymous bearer share corporations as well. We do not consider elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip Barbados a valid privacy oriented jurisdiction. This is one to avoid tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Once Bitten, Twice Shy, Third Time Stupid Residual Income is the Key to Financial Freedom
|